HOME >> BIOLOGY >> NEWS
Vascular Surgeons Test New Treatment For Abdominal Aneurysms

Vascular surgeons at Johns Hopkins are participating in a nationwide test of a procedure that uses 3-D images and a metal-supported cloth tube to repair stretched and weakened abdominal arteries before they burst and kill.

The tube, called a stent graft, is implanted in the abdominal aorta -- the main artery supplying blood to the lower body -- through a small incision in the groin. Blood then passes through the stent graft, taking pressure off the large and weak aorta, and reducing or eliminating the risk of rupture and death.

"This seems to be a safe and effective alternative to major surgery," says G. Melville Williams, M.D., chief of vascular surgery and lead investigator for the trial. "Previous studies show patients are out of the hospital quicker, have much less pain and return to pre-operative functioning much faster. Patients usually are discharged on the second day after the procedure, provided tests show the aneurysm is excluded from circulation."

Called silent killers because they often cause no symptoms, aneurysms occur in more than 5 percent of people age 60 and older. The incidence is higher among smokers, although aneurysms usually occur as the normal wear-and-tear aging process weakens the arterial wall. Sometimes they result from trauma or acute or chronic infections. They can be fatal if they leak or rupture.

About 75 percent of aneurysms go undiagnosed unless found unexpectedly during physical exams or picked up on X-rays taken for unrelated reasons.

In the current study, at 16 centers nationwide, physicians take 3-D computed tomography images of the abdomen to determine the exact anatomy of the aneurysm. If physicians feel the stent graft is suitable, it is inserted through an opening in the groin's femoral artery and threaded into the aneurysm using fluoroscopy, or X-ray imaging. The stent's metallic frame is flexible at col
'"/>

Contact: Karen Infeld
kinfeld@welchlink.welch.jhu.edu
(410) 955-1534
Johns Hopkins Medical Institutions
20-Mar-1998


Page: 1 2

Related biology news :

1. Vascular access vital to pump up tissue engineering
2. Vascular disease and aging
3. Study Links Viruses And Vascular Diseases
4. Surgeons explore new treatment for Tourette syndrome
5. Surgeons to train on artificial bodies
6. Columbia University College of Physicians and Surgeons receives $2.4 Million grant from Howard Hughes Medical Institute
7. Artificial Heart Chamber And Artificial Blood Vessels Aid Cardiovascular Surgeons
8. St. Petersburg/New Haven Partnership for HIV/AIDS Care, Treatment and Support launched
9. Treatment stimulates growth and regeneration of injured adult skeletal muscle
10. Treatment of lupus in mice may point the way to human treatment
11. Treatment in mice proves effective against Duchenne muscular dystrophy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/1/2016)... NEW YORK , Feb. 1, 2016  Today, ... Heart Association (AHA) announced plans to develop a first ... cognitive computing power of IBM Watson. In the first ... disease, AHA, IBM (NYSE: IBM ), and Welltok ... metrics and health assessments with cognitive analytics, delivered on ...
(Date:1/25/2016)... SEATTLE , Jan. 25, 2016  Glencoe Software, ... biotech, pharma and publication industries, will provide the data ... Phenotypic Screening Centre (NPSC). ... Phenotypic analysis ... even whole organisms, allowing comparisons between states such as ...
(Date:1/20/2016)... , Jan. 20, 2016   MedNet Solutions , ... entire spectrum of clinical research, is pleased to announce ... significant achievements are the result of the company,s laser ... iMedNet eClinical , it,s comprehensive, easy-to-use and highly ... --> Key MedNet growth achievements in 2015 ...
Breaking Biology News(10 mins):
(Date:2/5/2016)... , Feb. 5, 2016  In the pharmaceutical industry ... a host of launch activities including the identification and ... launch activity is especially high in the oncology therapeutic ... Best Practices and the Role of Medical Affairs in ... focused on oncology therapies find better ways to utilize ...
(Date:2/4/2016)... LEXINGTON, Massachusetts , February 4, 2016 - New ... --> - New FDA action date of July ... date of July 22, 2016   - ... the U.S. in the past decade indicated for the treatment of signs and ... Lifitegrast has the potential to be the only product approved in the ...
(Date:2/4/2016)... 4, 2016  CytoSorbents Corporation (NASDAQ: CTSO ... flagship CytoSorb® blood filter to treat deadly inflammation ... world, announced that CEO Dr. Phillip Chan ... Capital Group,s 2016 Disruptive Growth & Healthcare Conference, ... Conference Presentation Details: Where: Convene ...
(Date:2/4/2016)... , Feb. 4, 2016 Sinovac Biotech ... a leading provider of biopharmaceutical products in ... of its board of directors received on February 4, ... 2016, from a consortium comprised of PKU V-Ming ( ... Biomedicine Co., Ltd., CICC Qianhai Development ( Shenzhen ...
Breaking Biology Technology:
Cached News: